Skip to content

Levodopa

Levodopa is a standard medication associated with brands like Sinemet, Sinemet CR and Stalevo. This page lists 3 available products for addressing complex motor symptoms. As a precursor to dopamine, it is a primary treatment modality used to manage involuntary movement symptoms. Below you will find the available formulations.

Sinemet

Parkinson's Disease

10/100 · 25/100 · 25/250mg

Carbidopa with levodopa in three tablet strengths, plain and prolonged-release, used in the management of Parkinson's disease. A precursor with its protector.

From$0.57/ tabletView

Stalevo

Parkinson's Disease

25/100/200mg

Carbidopa, levodopa and entacapone in one film-coated tablet, used in the management of Parkinson's disease. A precursor with two enzyme blockers.

From$0.95/ tabletView

Sinemet CR

Parkinson's Disease

25/100mg

Sinemet CR is carbidopa with levodopa 25/100mg in a modified-release tablet for Parkinson's disease, spreading the dose across a longer period.

From$0.77/ tabletView

Key points

  • Crosses the blood-brain barrier and is converted into dopamine, replenishing the neurotransmitter that Parkinson’s disease depletes.
  • Comes in several release profiles, including standard, prolonged-release and modified-release tablets, to help keep dopamine levels steady.
  • Involuntary movements called dyskinesia can develop as the body adjusts, alongside a drop in blood pressure on standing.

What is Levodopa?

Levodopa is a pharmaceutical agent classified as an aromatic amino acid, used primarily to support motor function in neurological care. Because different individuals respond to varying release speeds and delivery methods, manufacturers produce multiple options, from standard tablets to modified-release formats. These variations allow for consistency in symptom management.

What Levodopa is used for

This medication is used for Parkinson’s Disease. It addresses motor symptoms by entering the central nervous system, where it converts into dopamine. By increasing dopamine concentrations in the brain, it supports the recovery of motor control in conditions affecting neuronal integrity.

How does Levodopa work?

Levodopa crosses the blood-brain barrier, a protective separation between circulating blood and the brain. Once inside, an enzyme converts the molecule into dopamine, a neurotransmitter essential for smooth, coordinated movement. This replenishment addresses the deficit caused by the disease, allowing for improved muscle function.

Levodopa brands and forms

Choosing the correct brand and format is a key part of Neurology treatment. Well-known options such as Sinemet, Sinemet CR, Caramet and Duodopa provide various pharmacological profiles. Patients and clinicians select between different release mechanisms, such as a Tablet, Prolonged-release tablet, Modified-release tablet, or Film-coated tablet, to maintain stable levels in the bloodstream throughout the day.

Safety overview for Levodopa

What to check before using this medicine

Verify that you understand the release mechanism of your specific tablet, as prolonged-release versions differ from standard ones. Ensure that your current medical history is thoroughly reviewed to avoid contraindications.

Possible reactions and tolerability

Common reactions may include nausea, dizziness, or orthostatic hypotension, which is a drop in blood pressure when standing. Sudden involuntary movements, known as dyskinesia, can also materialize as the body adjusts to the medication.

Interactions and health factors

Concurrent use of other medications, particularly certain blood pressure agents or antipsychotics, can alter the efficacy of Levodopa. Product labelling and verified clinical sources remain the correct references for specific contraindications, interactions and reactions.

Further reading